Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Jun;45(6):494–497. doi: 10.1136/jcp.45.6.494

Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.

M Lehtinen 1, A Leminen 1, J Paavonen 1, P Lehtovirta 1, H Hyöty 1, E Vesterinen 1, J Dillner 1
PMCID: PMC495222  PMID: 1320634

Abstract

AIMS: To determine if there are type specific differences in serum antibody responses to synthetic peptides derived from human papillomavirus (HPV) open reading frame (ORF) E2 in patients with cervical carcinoma. METHODS: Diagnostic phase sera from 88 age-matched women with cervical adenocarcinoma (AC), cervical squamous cell carcinoma (SC), ovarian cancer (OC) or no gynaecological malignancy were available. Serum IgG and IgA antibodies to synthetic peptides corresponding to a residue of HPV 6, 11, 16, and 18 ORF E2 18 amino acids long and a control peptide from mumps virus were determined by ELISA. RESULTS: Both IgA and IgG antibody positivity to the HPV 18 peptide were associated with increased risk (9.0-fold, confidence limits 1.5-199) for AC. IgA positivity to HPV 11, 16, and 18 peptides was associated with an increased risk for SC. However, the association of IgG antibodies to HPV 16 peptide with SC was not significant. IgA or IgG antibodies to HPV 6 or mumps virus peptides were not associated with increased risk for AC, SC, or OC. CONCLUSIONS: These results suggest a specific role for HPV 18 in AC. Differences in antibody responses to HPV peptide in AC and SC suggest immunopathogenetic differences between the two types of cervical carcinoma.

Full text

PDF
494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biggar R. J., Nkrumah F. K., Henle W., Levine P. H. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies. J Natl Cancer Inst. 1981 Mar;66(3):439–444. [PubMed] [Google Scholar]
  2. Cole S. T., Danos O. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol. 1987 Feb 20;193(4):599–608. doi: 10.1016/0022-2836(87)90343-3. [DOI] [PubMed] [Google Scholar]
  3. Crum C. P., Symbula M., Ward B. E. Topography of early HPV 16 transcription in high-grade genital precancers. Am J Pathol. 1989 Jun;134(6):1183–1188. [PMC free article] [PubMed] [Google Scholar]
  4. Cullen A. P., Reid R., Campion M., Lörincz A. T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991 Feb;65(2):606–612. doi: 10.1128/jvi.65.2.606-612.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dartmann K., Schwarz E., Gissmann L., zur Hausen H. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology. 1986 May;151(1):124–130. doi: 10.1016/0042-6822(86)90110-8. [DOI] [PubMed] [Google Scholar]
  6. Dillner J., Dillner L., Robb J., Willems J., Jones I., Lancaster W., Smith R., Lerner R. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A. 1989 May;86(10):3838–3841. doi: 10.1073/pnas.86.10.3838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dillner J. Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer. 1990 Oct 15;46(4):703–711. doi: 10.1002/ijc.2910460426. [DOI] [PubMed] [Google Scholar]
  8. Köchel H. G., Monazahian M., Sievert K., Höhne M., Thomssen C., Teichmann A., Arendt P., Thomssen R. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls. Int J Cancer. 1991 Jul 9;48(5):682–688. doi: 10.1002/ijc.2910480509. [DOI] [PubMed] [Google Scholar]
  9. Leminen A., Paavonen J., Vesterinen E., Wahlström T., Rantala I., Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol. 1991 May;95(5):647–652. doi: 10.1093/ajcp/95.5.647. [DOI] [PubMed] [Google Scholar]
  10. Li C. C., Gilden R. V., Showalter S. D., Shah K. V. Identification of the human papillomavirus E2 protein in genital tract tissues. J Virol. 1988 Feb;62(2):606–609. doi: 10.1128/jvi.62.2.606-609.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mann V. M., de Lao S. L., Brenes M., Brinton L. A., Rawls J. A., Green M., Reeves W. C., Rawls W. E. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res. 1990 Dec 15;50(24):7815–7819. [PubMed] [Google Scholar]
  12. Muñoz N., Bosch X., Kaldor J. M. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer. 1988 Jan;57(1):1–5. doi: 10.1038/bjc.1988.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Okagaki T., Tase T., Twiggs L. B., Carson L. F. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. J Reprod Med. 1989 Sep;34(9):639–644. [PubMed] [Google Scholar]
  14. Schwarz E., Dürst M., Demankowski C., Lattermann O., Zech R., Wolfsperger E., Suhai S., zur Hausen H. DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J. 1983;2(12):2341–2348. doi: 10.1002/j.1460-2075.1983.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Seedorf K., Krämmer G., Dürst M., Suhai S., Röwekamp W. G. Human papillomavirus type 16 DNA sequence. Virology. 1985 Aug;145(1):181–185. doi: 10.1016/0042-6822(85)90214-4. [DOI] [PubMed] [Google Scholar]
  16. Young F. I., Ward L. M., Brown L. J. Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridisation. J Clin Pathol. 1991 Apr;44(4):340–341. doi: 10.1136/jcp.44.4.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 1989 Sep 1;49(17):4677–4681. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES